The STING/TBK1/IRF3/IFN type I pathway is defective in cystic fibrosis.
Occhigrossi L, Rossin F, Villella VR, Esposito S, Abbate C, D'Eletto M, Farrace MG, Tosco A, Nardacci R, Fimia GM, Raia V, Piacentini M.
Occhigrossi L, et al. Among authors: piacentini m.
Front Immunol. 2023 Feb 27;14:1093212. doi: 10.3389/fimmu.2023.1093212. eCollection 2023.
Front Immunol. 2023.
PMID: 36923406
Free PMC article.